CVS Health Misses 2026 Profit Forecast, Shares Drop
CVS Health falls short of Wall Street's 2026 profit expectations despite beating Q4 estimates. Stock drops 3% as company maintains cautious outlook amid healthcare industry challenges.
CVS Health falls short of Wall Street's 2026 profit expectations despite beating Q4 estimates. Stock drops 3% as company maintains cautious outlook amid healthcare industry challenges.
Spotify adds 38M users in Q4 2025, beating forecasts. Stock jumps 10% as new co-CEOs deliver strong earnings, higher margins, and optimistic Q1 outlook despite slowing revenue growth.
Coca-Cola misses Q4 revenue expectations as North American demand weakens. Company projects 4-5% organic growth for 2026 despite headwinds from weight-loss drugs and healthier consumer choices.
TSMC reports strong 37% revenue growth in January 2026, exceeding annual targets as AI chip demand drives record capital spending and potential US tariff exemptions.
BP suspends buybacks to strengthen balance sheet amid struggling renewables, $22B debt, and falling oil prices. Shares drop 5% as company shifts focus.
Morgan Stanley resumes coverage of Qualcomm with an Underweight rating, citing optimized earnings and memory shortages that could pressure Android phone demand in 2026.